Dome Centric component (Reference 01.04227.005) from the Anatomical Shoulder (AS) System 2.0. Th...

FDA Device Recall #Z-2003-2016 — Class II — May 17, 2016

Recall Summary

Recall Number Z-2003-2016
Classification Class II — Moderate risk
Date Initiated May 17, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Zimmer Gmbh
Location Winterthur
Product Type Devices
Quantity 177

Product Description

Dome Centric component (Reference 01.04227.005) from the Anatomical Shoulder (AS) System 2.0. The Dome Centric connects the Humeral Stem to the Humeral Head and allows setting an inclination and retroversion positioning. The Anatomical Shoulder System is intended for long-term implantation into the human shoulder joint in primary or revision, total or hemi shoulder arthroplasty. The system is intended to relieve pain and restore function in patients with adequate bone stock to support the prosthesis.

Reason for Recall

In some cases it has been difficult or not possible to disassemble the adjusted Dome Centric from the AS Humeral Rasp after initial positioning of the AS Humeral Trial Head which resulted in the whole construct of the Dome Centric with the still assembled AS Humeral Rasp taken out of the humeral canal. This could cause a delay in surgery time or the surgeon could decide to close the wound without finishing the surgery, increasing the infection risk or second use of anesthesia necessary.

Distribution Pattern

Nationwide Distribution to AZ, CA, CO, GA, IL, KS, KY, MA, MD, MO, OH, PA, TN, and TX.

Lot / Code Information

Item Number: 01.04227.005 Lot Numbers: 2792457 2794578 2812029 2817212 2844463 2794576 2794579 2815118 2817213 2847568 2794577 2794580 2815119 2832862

Other Recalls from Zimmer Gmbh

Recall # Classification Product Date
Z-3132-2024 Class II Biolox Option Taper Sleeve, Type 1 Taper, Stand... Aug 8, 2024
Z-3133-2024 Class II Biolox Option Taper Sleeve, Type 1 Taper, -6mm ... Aug 8, 2024
Z-1793-2021 Class II Zimmer Natural Nail- ZNN Cephalomedullary Short... May 7, 2021
Z-1792-2021 Class II Zimmer Natural Nail -ZNN Cephalomedullary Short... May 7, 2021
Z-2762-2019 Class II Sidus Stem-Free Shoulder Humeral Head 50-18 It... Aug 21, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.